Olfr10 inhibitors encompass a range of chemicals that indirectly influence the activity of the olfactory receptor family 2 subfamily Y member 1B (Olfr10). These inhibitors are not direct antagonists of the receptor but operate by modulating the G protein-coupled receptor (GPCR) signaling pathways, which are integral to the function of olfactory receptors. GPCRs are a large family of cell surface receptors that respond to a variety of external signals and are pivotal in numerous physiological processes, including the detection of odors. The chemicals listed as Olfr10 inhibitors include a diverse set of GPCR antagonists and modulators. For instance, beta-adrenergic receptor antagonists like Propranolol and Metoprolol can indirectly influence the signaling pathways involving G proteins, which are crucial for the activation of olfactory receptors like Olfr10. Similarly, antipsychotics and antidepressants like Chlorpromazine and Clozapine, known for their antagonistic effects on dopamine receptors, can modulate GPCR activity. This modulation is significant because it can lead to altered G protein-mediated responses, indirectly affecting the function of olfactory receptors.
In addition to these, antihistamines (e.g., Cyproheptadine, Cimetidine) and serotonin receptor antagonists (e.g., Ondansetron, Ritanserin) play a role in modulating GPCR signaling. The alteration in histamine and serotonin receptor activities can have a cascading effect on the signaling pathways associated with olfactory receptors. Alpha-adrenergic antagonists like Yohimbine and Phenoxybenzamine further expand the scope of GPCR modulation, suggesting a broad range of chemicals that can indirectly influence Olfr10 activity. These inhibitors, through their varied interaction with different GPCR subtypes, underscore the complexity of the GPCR signaling networks and their influence on olfactory receptor activity. Understanding the nuances of these interactions is vital for grasping how these chemicals can indirectly inhibit Olfr10. The potential of these compounds to influence olfactory receptor activity makes them relevant in the context of studying GPCR-mediated processes and the modulation of sensory perception at the molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
A non-selective beta-adrenergic receptor antagonist, Propranolol can indirectly affect GPCR signaling, potentially influencing Olfr10 activity by altering G protein-mediated responses. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $60.00 $108.00 | 21 | |
Chlorpromazine, a dopamine antagonist, can modulate GPCR activity. Its impact on dopamine receptors may indirectly affect GPCR-mediated olfactory transduction. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $50.00 $168.00 $520.00 | 2 | |
Yohimbine, an alpha-2 adrenergic receptor antagonist, may alter GPCR signaling, indirectly influencing Olfr10 activity in olfactory processes. | ||||||
Cimetidine | 51481-61-9 | sc-202996 sc-202996A | 5 g 10 g | $62.00 $86.00 | 1 | |
A histamine H2 receptor antagonist, Cimetidine can indirectly influence GPCR-mediated signal transduction, potentially affecting Olfr10. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A | 50 mg 500 mg | $68.00 $357.00 | 11 | |
As an atypical antipsychotic, Clozapine's antagonistic effects on various dopamine receptors may indirectly affect GPCR signaling relevant to Olfr10. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
Haloperidol, a dopamine antagonist, can modulate GPCR activity, potentially influencing olfactory signaling pathways involving Olfr10. | ||||||
Ondansetron | 99614-02-5 | sc-201127 sc-201127A | 10 mg 50 mg | $80.00 $326.00 | 1 | |
As a serotonin 5-HT3 receptor antagonist, Ondansetron can indirectly affect GPCR signaling, potentially altering Olfr10 function in olfactory transduction. | ||||||
Ritanserin | 87051-43-2 | sc-203681 sc-203681A | 10 mg 50 mg | $87.00 $306.00 | 2 | |
Ritanserin, a serotonin receptor antagonist, can modulate GPCR activity, potentially influencing olfactory receptors including Olfr10. | ||||||
(RS)-(±)-Sulpiride | 15676-16-1 | sc-205494 | 100 mg | $69.00 | ||
A dopamine antagonist, Sulpiride can influence GPCR signaling, potentially affecting pathways related to Olfr10. | ||||||